3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Tourette Syndrome
1
Stress Disorders, Post-Traumatic
1
Sleep Initiation and Maintenance Disorders
1
Severe Acute Respiratory Syndrome
1
Seizures
1
Parkinson Disease
1
Opioid-Related Disorders
1
Neoplasms
1
Multiple Sclerosis
1
Inflammatory Bowel Diseases
1
Hepatitis C
1
Glaucoma
1
Fibromyalgia
1
Epilepsy
1
Depression
1
Crohn Disease
1
Coronavirus Infections
1
Colitis, Ulcerative
1
Chronic Traumatic Encephalopathy
1
Chronic Pain
1
COVID-19
1
Brain Injuries, Traumatic
1
Bipolar Disorder
1
Autistic Disorder
1
Anxiety Disorders
1
Anemia, Sickle Cell
1
Amyotrophic Lateral Sclerosis
1
Acquired Immunodeficiency Syndrome
1
Interventions
Therapeutics
3
Psychiatric Rehabilitation
3
Mindfulness-Based Cognitive Therapy
3
Cognitive Behavioral Therapy
3
Vortioxetine
2
Metformin
2
Early Intervention, Educational
2
drospirenone
1
Whole Body Imaging
1
Standard of Care
1
Single Person
1
Referral and Consultation
1
Radiosurgery
1
Psilocybin
1
Pharmacogenomic Testing
1
Motion
1
Modafinil
1
Mirtazapine
1
Microscopy, Interference
1
Methylphenidate
1
Methods
1
Mental Status and Dementia Tests
1
Meditation
1
Medical Marijuana
1
Massage
1
Ketamine
1
Interviews as Topic
1
Ethinyl Estradiol
1
Educational Status
1
Coping Skills
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Depression
×
Medical Marijuana
×
Clear all
NCT03944447
2022-06-02
OMNI-Can
OMNI Medical Services, LLC
Phase 2
Unknown
200,000 enrolled